Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17140-78-2

17140-78-2

Post Buying Request

17140-78-2 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

17140-78-2 Usage

Uses

Analgesic.

Brand name

Darvon-N (Xanodyne).

Check Digit Verification of cas no

The CAS Registry Mumber 17140-78-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,1,4 and 0 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17140-78:
(7*1)+(6*7)+(5*1)+(4*4)+(3*0)+(2*7)+(1*8)=92
92 % 10 = 2
So 17140-78-2 is a valid CAS Registry Number.
InChI:InChI=1/C22H29NO2.C10H8O3S/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19;11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10/h6-15,18H,5,16-17H2,1-4H3;1-7H,(H,11,12,13)/t18-,22-;/m1./s1

17140-78-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name PROPOXYPHENE NAPSYLATE

1.2 Other means of identification

Product number -
Other names Propoxyphen napsylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17140-78-2 SDS

17140-78-2Upstream product

17140-78-2Downstream Products

17140-78-2Related news

The effectiveness and side-effect liability of propoxyphene hydrochloride and PROPOXYPHENE NAPSYLATE (cas 17140-78-2) in patients with postpartum uterine cramping08/19/2019

A balanced Latin square design was used to evaluate the effectiveness and acceptability of 2 propoxyphene salts in consenting postpartum patients with pain. Attention was paid to the intensity of pain and its change on treatment, an estimate of pain relief, and the frequency and intensity of sym...detailed

PROPOXYPHENE NAPSYLATE (cas 17140-78-2) maintenance treatment for narcotic dependence: A non-methadone model08/17/2019

One hundred and seventy eight heroin addicts entered propoxyphene napsylate (PN) maintenance. Patients attended a general medical clinic twice each week and took home a three- to four-day supply of PN, to be taken in doses of 300 to 400 mg three or four times per day. Over a 21-month period, sub...detailed

A study of propoxyphene and salicylate concentrations in human plasma following the administration of PROPOXYPHENE NAPSYLATE (cas 17140-78-2) and aspirin08/16/2019

The absorption of propoxyphene napsylate from tablets, capsules, and a suspension formulation, as measured by concentrations in the plasma of 10 human male subjects, reveals that the tablet and capsule are equivalent solid dosage forms. The suspension affords a significantly higher plasma concen...detailed